Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Functional antagonism of chromatin modulators regulates EMT [ATAC-Seq]

ABSTRACT: Functional antagonism of chromatin modulators regulates EMT [ATAC-Seq]

PROVIDER: PRJNA648648 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12323001_1.fastq.gz	Fastqsanger.gz
	SRR12323001_2.fastq.gz	Fastqsanger.gz
	SRR12323002_1.fastq.gz	Fastqsanger.gz
	SRR12323002_2.fastq.gz	Fastqsanger.gz
	SRR12323003_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 20

Similar Datasets

Functional antagonism of chromatin modulators regulates EMT

Project description:Functional antagonism of chromatin modulators regulates EMT

| PRJNA648646 | ENA

Functional antagonism of chromatin modulators regulates EMT [ChIP-Seq]

Project description:Functional antagonism of chromatin modulators regulates EMT [ChIP-Seq]

| PRJNA648647 | ENA

Functional antagonism of chromatin modulators regulates EMT [ATAC-Seq]

Project description:Genome-wide chromatin analyses to validate the CRISPR interference screen for modulators of mesenchymal signaling reporter in A549 and H1944 cells. ATAC-seq in naive, GSK126- and TGFB-treated A549 cells. ChIP-seq in naive A549 cells for chromatin modulators, ChIP-seq in naive and GSk126-treated cells from RNAPII in A549 cells.

2021-07-16 | GSE155116 | GEO

Functional antagonism of chromatin modulators regulates EMT [ChIP-Seq]

2021-07-16 | GSE155115 | GEO

Functional antagonism of chromatin modulators regulates EMT

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-07-16 | GSE155117 | GEO

Overexpression of the EMT modulator SNAI1 in HPC7 cells

Project description:Modulators of epithelial to mesenchymal transition (EMT) have recently emerged as novel players in the field of leukemia biology. The mechanisms by which EMT modulators contribute to leukemia pathogenesis, however, remain to be elucidated. Here we investigate the role SNAI1 - a key modulator of EMT – and its effect on chromatin state using ATAC-seq in hematopoietic cells (HPC7).

2023-04-01 | GSE147873 | GEO

Functional antagonism of chromatin modulators regulates epithelial-mesenchymal transition.

Project description:Epithelial-mesenchymal transition (EMT) is a developmental process hijacked by cancer cells to modulate proliferation, migration, and stress response. Whereas kinase signaling is believed to be an EMT driver, the molecular mechanisms underlying epithelial-mesenchymal interconversion are incompletely understood. Here, we show that the impact of chromatin regulators on EMT interconversion is broader than that of kinases. By combining pharmacological modulation of EMT, synthetic genetic tracing, and CRISPR interference screens, we uncovered a minority of kinases and several chromatin remodelers, writers, and readers governing homeostatic EMT in lung cancer cells. Loss of ARID1A, DOT1L, BRD2, and ZMYND8 had nondeterministic and sometimes opposite consequences on epithelial-mesenchymal interconversion. Together with RNAPII and AP-1, these antagonistic gatekeepers control chromatin of active enhancers, including pan-cancer-EMT signature genes enabling supraclassification of anatomically diverse tumors. Thus, our data uncover general principles underlying transcriptional control of cancer cell plasticity and offer a platform to systematically explore chromatin regulators in tumor-state-specific therapy.

| S-EPMC7904264 | biostudies-literature

Proteome landscape of epithelial to mesenchymal transition (EMT) of retinal pigment epithelium shares commonalities with malignancy-associated EMT

Project description:Retinal pigment epithelium (RPE) stress and injury often leads to epithelial to mesenchymal transition (EMT), in which RPE cells lose its cobblestone morphology and acquire more motile and spindle-shaped fibroblast phenotype. RPE dysfunction due to acquired EMT phenotype have been implicated in a number of retinal diseases such as proliferative vitreoretinopathy (PVR), diabetic retinopathy (DR), neovascular (“wet”) and atrophic (“dry”) age-related macular degeneration (AMD). We investigated distinct temporal protein expression changes and signaling events that occur during enzymatically dissociated hRPE EMT model, as well as those that occur up to forty-eight hours after EMT onset. Further, we compared analysis on altered proteome profiling with malignancy associated EMT and AMD models. Together, proteome profiles provide a comprehensive RPE EMT resources for understanding molecular signaling events, associated biological pathways, that underlie RPE-EMT onset and further identifying chemical modulators that could potentially inhibit RPE EMT.

2021-09-21 | PXD019600 | Pride

Identification of the tumour transition states occurring during EMT [ATAC-seq]

Project description:EMT (epithelial-mesenchymal transition) in cancer has been associated with tumour stemness, metastasis and resistance to therapy. It has recently been proposed that, rather than being a binary process, EMT occurs through distinct intermediate states. However,direct in vivo evidence supporting this possibility is still lacking. By screening a large panel of cell surface markers, we identified the existence of multiple tumour subpopulations associated with different EMT stages from epithelial to completely mesenchymal states passing through intermediate hybrid states in skin and mammary primary tumours. Although all EMT subpopulations presented similar tumour propagating cell capacity, they displayed different, invasiveness and metastatic potential. Their transcriptional and epigenetic landscapes defined by RNA-seq and ATAC-seq identified the underlying gene regulatory networks, transcription factors and signalling pathways that control these different EMT transition states. Finally, these tumour subpopulations are localized in different niches that differentially regulateEMT transition states.

2018-02-15 | GSE110584 | GEO

Epigenetic profiling of EMT in pancreatic cancer cells (ATAC-seq)

Project description:Epigenetic profiling of EMT in pancreatic cancer cells (ATAC-seq)

| PRJNA565772 | ENA